Tag: VNS
Vagus nerve stimulation demonstrates promise as non-medical treatment for narcolepsy
An initial evaluation of vagus nerve stimulation (VNS) in narcolepsy patients has linked this neuromodulation modality to a “significant improvement” in daytime sleepiness, leading...
Non-invasive VNS approach could enhance post-stroke recovery outcomes
A novel approach to vagus nerve stimulation (VNS) may enable successful post-stroke recovery without the need for “invasive and often-uninsured” traditional VNS therapies.
A paper published...
Evren Technologies launches Phoenix 100 system for vagus nerve stimulation research
Evren Technologies has announced the launch of its Phoenix 100 system, a “state-of-the-art” transcutaneous auricular vagus nerve stimulator (taVNS) research tool.
The Phoenix 100 system is intended...
RECOVER trial will provide “thorough understanding” of VNS response in depression...
A new randomised controlled trial (RCT)—the “largest ever” of its kind in the major depressive disorder (MDD) space—will attempt to provide a “thorough understanding”...
Evidence indicates effectiveness of brain stimulation in upper-limb stroke rehabilitation
Moderate- to high-quality evidence suggests that specific neuromodulation modalities can provide effective treatments in patients undergoing stroke rehabilitation. As per a systematic review and...
Feinstein Institutes reports on early vagus nerve mapping and details novel...
Researchers at the Feinstein Institutes for Medical Research (Manhasset, USA) are microscopically mapping more than 100,000 individual fibres that make up the vagus nerve...
Transcutaneous auricular VNS proves effective in patients with mild cognitive impairment
A double-blinded randomised controlled trial (RCT) has shown that transcutaneous auricular vagus nerve stimulation (taVNS) can improve cognitive performance in patients with mild cognitive...
Clinical trial to test novel wearable treatment for chronic pain and...
A multi-year clinical trial at the University of Texas Medical Branch (UTMB; Galveston, USA) and Medical University of South Carolina (MUSC; Charleston, USA) will...
Neuromodulation offers hope for patients with long-COVID
With increasing focus being placed on the long-term impact COVID-19 can have, and the demand for effective treatments also growing concurrently, Marom Bikson (New...
Neuromodulation for post-stroke recovery advancing on several fronts
As a principal investigator for the pivotal VNS-REHAB study, which supported the first US Food and Drug Administration (FDA) premarket approval of a vagus...
Dolphin vagus nerve stimulation receives Health Canada approval as COVID-19 treatment
Center for Pain and Stress Research today announced that its Dolphin vagus nerve stimulation (VNS) device has received breakthrough approval from Health Canada—making it...
Feinstein Institutes scientists develop “first-of-its-kind” wireless neuromodulation device for research
Engineers and researchers in the Institute of Bioelectronic Medicine at the Feinstein Institutes for Medical Research have developed a novel, fully implantable, wireless bidirectional vagus nerve stimulation (VNS)...
MicroTransponder receives best new product award for Vivistim system
MicroTransponder today announced that its Vivistim paired vagus nerve stimulation (VNS) system has won the Neurotech Reports Gold Electrode Award for best new product. This announcement...
MicroTransponder gains FDA approval for first-of-its-kind VNS system to improve stroke...
MicroTransponder has announced US Food and Drug Administration (FDA) premarket approval of the Vivistim paired vagus nerve stimulation (VNS) system, which—according to a company...
New study shows significant positive impact of vagus nerve stimulation therapy...
Adding vagus nerve stimulation (VNS) therapy to treatment as usual has been demonstrated to improve outcomes in patients with treatment-resistant bipolar depression (TRBD). In...
RECOVER trial design evaluating vagus nerve stimulation for treatment-resistant depression published
LivaNova announces a publication in Contemporary Clinical Trials, which details the design for a prospective, multicentre, randomised controlled blinded trial demonstrating the safety and...
Non-invasive vagus nerve stimulation may provide clinical benefit to patients with...
An article accepted into the journal Neuromodulation has concluded that, based on two case reports, non-invasive vagus nerve stimulation (nVNS) might provide clinical benefits...
LivaNova’s VNS Therapy receives CE mark for expanded MRI labelling
LivaNova's latest VNS Therapy system has received CE mark for expanded MRI labelling. VNS Therapy is now the only implantable device indicated for epilepsy...
